Vicapsys Life Sciences, Inc.
VICP · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $0 | $4 | $10 |
| G&A Expenses | $0 | $0 | $133 | $109 |
| SG&A Expenses | $173 | $229 | $133 | $109 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $63 | $63 |
| Operating Expenses | $173 | $229 | $199 | $182 |
| Operating Income | -$173 | -$229 | -$199 | -$182 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$8 | -$8 | -$37 | -$8 |
| Pre-Tax Income | -$181 | -$237 | -$236 | -$190 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$181 | -$237 | -$236 | -$190 |
| % Margin | – | – | – | – |
| EPS | -0.005 | -0.007 | -0.007 | -0.006 |
| % Growth | 30.1% | -5.8% | -23.2% | – |
| EPS Diluted | -0.005 | -0.007 | -0.007 | -0.006 |
| Weighted Avg Shares Out | 35,371 | 32,371 | 34,328 | 34,188 |
| Weighted Avg Shares Out Dil | 35,371 | 32,371 | 34,328 | 34,188 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8 | $8 | $37 | $8 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$173 | -$229 | -$199 | -$182 |
| % Margin | – | – | – | – |